Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen Sells 128,726 Shares

Agilent Technologies, Inc. (NYSE:AGet Rating) CEO Michael R. Mcmullen sold 128,726 shares of the firm’s stock in a transaction that occurred on Tuesday, November 22nd. The stock was sold at an average price of $155.73, for a total value of $20,046,499.98. Following the sale, the chief executive officer now directly owns 260,691 shares of the company’s stock, valued at $40,597,409.43. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Agilent Technologies Trading Down 1.0 %

Shares of NYSE:A opened at $155.35 on Thursday. Agilent Technologies, Inc. has a 12-month low of $112.52 and a 12-month high of $162.62. The business’s fifty day simple moving average is $133.55 and its 200-day simple moving average is $128.29. The company has a market capitalization of $45.99 billion, a PE ratio of 37.25, a P/E/G ratio of 2.78 and a beta of 1.06. The company has a current ratio of 2.03, a quick ratio of 1.41 and a debt-to-equity ratio of 0.52.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.14. Agilent Technologies had a return on equity of 30.31% and a net margin of 18.31%. The business had revenue of $1.85 billion for the quarter, compared to the consensus estimate of $1.76 billion. During the same period last year, the business posted $1.21 EPS. The business’s revenue was up 11.4% compared to the same quarter last year. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.64 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.225 per share. This represents a $0.90 annualized dividend and a yield of 0.58%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Friday, December 30th. Agilent Technologies’s payout ratio is 20.14%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on A shares. Jefferies Financial Group raised their price target on Agilent Technologies from $158.00 to $168.00 in a research note on Tuesday. Cowen raised their price target on Agilent Technologies from $160.00 to $168.00 in a research note on Tuesday. Robert W. Baird raised their price target on Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday. StockNews.com assumed coverage on Agilent Technologies in a report on Wednesday, October 12th. They set a “strong-buy” rating on the stock. Finally, Evercore ISI raised their price objective on Agilent Technologies from $140.00 to $155.00 in a report on Tuesday. Four investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $157.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in A. Bromfield Sneider Wealth Advisors acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at about $31,000. EverSource Wealth Advisors LLC lifted its holdings in Agilent Technologies by 34.8% in the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock valued at $37,000 after acquiring an additional 77 shares during the last quarter. Edge Capital Group LLC lifted its holdings in Agilent Technologies by 53.0% in the third quarter. Edge Capital Group LLC now owns 303 shares of the medical research company’s stock valued at $37,000 after acquiring an additional 105 shares during the last quarter. Guardian Wealth Advisors LLC acquired a new position in Agilent Technologies during the third quarter worth $42,000. Finally, J.W. Cole Advisors Inc. raised its stake in shares of Agilent Technologies by 7,201.6% in the first quarter. J.W. Cole Advisors Inc. now owns 124,493 shares of the medical research company’s stock valued at $45,000 after acquiring an additional 122,788 shares in the last quarter.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Stories

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.